MedTrace Logo

The Influence of Partial Remission Phase of Type 1 Diabetes on Patient Outcome

NCT02220257 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2014-08-19

No results posted yet for this study

Summary

Natural course of diabetes mellitus involves gradual reduction of β cell mass within islets of Langerhans in the pancreas. Symptoms of diabetes present when the mass of insulin-producing cells reaches a point where insulin concentration does not suffice to maintain proper glycaemia. In many patients β cells regenerate shortly after the diagnosis of diabetes and initiation of insulin therapy. This phenomenon is called a remission.

The aim of this study is to asses the influence of occurrence and duration of remission on development of chronic complications of diabetes and patients outcome.

Conditions

  • Diabetes Mellitus Type 1
  • Remission of Type 1 Diabetes
  • Chronic Complications of Diabetes

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Paweł Niedźwiecki, MD · Poznan University of Medical Sciences

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-08-31
Completion
2015-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02220257 on ClinicalTrials.gov